Clinical characteristics and hypersensitivity reactions to iodinated contrast media at E Hospital
Main Article Content
Abstract
Iodinated contrast media (ICM) are indispensable tools in diagnostic imaging; however, their use may be associated with unpredictable hypersensitivity reactions. We performed this cross-sectional descriptive study to evaluate clinical characteristics and associated factors. Data on demographic characteristics, history of allergy, type of ICM, and clinical manifestations were collected on 60 cases treated at E Hospital from July 2024 to July 2025. The results showed that 78.3% of reactions occurred within the first six hours, predominantly representing immediate hypersensitivity reactions. Cutaneous and mucocutaneous manifestations were observed in all cases, while respiratory and gastrointestinal symptoms were reported in 20% and 13.3% of patients, respectively. Grade I anaphylaxis accounted for 80%, whereas grade II anaphylaxis comprised 20%. There was no statistically significant difference between the two ICM types, Iopamiro and Omnipaque, with respect to reaction severity, onset time, or demographic characteristics and history of allergy. Hypersensitivity reactions to iodinated contrast media (ICM) at E Hospital were predominantly immediate and mild; in the absence of clear predictors of severe reactions, close post-injection monitoring remains essential to ensure patient safety.
Article Details
Keywords
Iodinated contrast media, hypersensitivity reactions, clinical characteristics, anaphylaxis, E Hospital
References
2. Brockow K. Allergy to Radiocontrast Dye. Immunol Allergy Clin North Am. 2022;42(2):391-401.
3. Torres MJ, Trautmann A, Bohm I, et al. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity. Allergy. 2021;76(5):1325-1339.
4. Brockow K, Christiansen C, Kanny G, et al. Management of hypersensitivity reactions to iodinated contrast media. Allergy. 2005;60(2):150-158.
5. Cha MJ, Kang DY, Lee W, et al. Hypersensitivity Reactions to Iodinated Contrast Media: A Multicenter Study of 196 081 Patients. Radiology. 2019;293(1):117-124.
6. Lee SY, Kang DY, Kim JY, et al. Incidence and Risk Factors of Immediate Hypersensitivity Reactions Associated With Low-Osmolar Iodinated Contrast Media: A Longitudinal Study Based on a Real-Time Monitoring System. J Investig Allergol Clin Immunol. 2019;29(6):444-450.
7. Đàm Thu Hiền, Nguyễn Lê Hà, Nguyễn Thị Thu Lan, Võ Như Quỳnh, Đỗ Ngọc Quý Dương, Đinh Thị Thu Lan, Nguyễn Minh Châu, Nguyễn Hoàng Phương, Lê Đình Tùng, Bùi Văn Dân. Khảo sát các phản ứng có hại liên quan đến chất cản quang chứa IOD tại Bệnh viện E năm 2025. Tạp chí nghiên cứu y học. 2025;194:47-55.
8. Cao Thị Thu Huyền, Trần Hoàng Hưng, Nguyễn Thị Thanh Hương, Vũ Đình Hòa, Nguyễn Hoàng Anh. Phản vệ liên quan đến thuốc cản quang chứa iod: Phân tích tín hiệu từ cơ sở dữ liệu báo cáo ADR Quốc gia trong giai đoạn 2015 - 2019. Tạp chí y dược lâm sàng 108. 2021;Hội nghị Khoa học Dược bệnh viện năm 2021.
9. Bộ Y tế. Hướng dẫn phòng, chẩn đoán và xử trí phản vệ 2017;Thông tư 51/2017/TT-BYT.
10. van der Molen AJ, van de Ven A, Vega F, et al. Hypersensitivity reactions to contrast media: Part 1. Management of immediate and non-immediate hypersensitivity reactions in adults. Updated guidelines by the ESUR Contrast Media Safety Committee. Eur Radiol. 2025;35(11):6798-6810.
11. Pinyopornpanish K, Phithakham C, Prakaikietikul P, Aramrat C, Pinyopornpanish K. Characterization of Hypersensitivity to Iodinated Contrast Media: Insights from a Six-Year Cohort of 26,465 Procedures. Healthcare (Basel). 2025;13(12).
12. Costantino MT, Romanini L, Gaeta F, et al. SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media. Clin Mol Allergy. 2020;18:13.
13. Katayama H, Yamaguchi K, Kozuka T, Takashima T, Seez P, Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology. 1990;175(3):621-628.
14. Brockow K, Ring J. Anaphylaxis to radiographic contrast media. Curr Opin Allergy Clin Immunol. 2011;11(4):326-331.
15. Thomsen HS. European Society of Urogenital Radiology (ESUR) guidelines on the safe use of iodinated contrast media. Eur J Radiol. 2006;60(3):307-313.